Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. (Q51036604)

27 March 2018

title

Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. (English)

1 reference

27 March 2018

1 reference

2

1 reference

27 March 2018

author name string

Christoph Laske

1

1 reference

27 March 2018

Nadine Hoffmann

3

1 reference

27 March 2018

Elke Stransky

4

1 reference

27 March 2018

Guido Straten

5

1 reference

27 March 2018

Gerhard W Eschweiler

6

1 reference

27 March 2018

Thomas Leyhe

7

1 reference

27 March 2018

publication date

22 September 2010

1 reference

27 March 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

27 March 2018

volume

14

1 reference

27 March 2018

page(s)

399-404

1 reference

27 March 2018

issue

3

1 reference

27 March 2018

Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Sustained phosphorylation and activation of protein kinase B correlates with brain-derived neurotrophic factor and insulin stimulated survival of cerebellar granule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

BDNF is essential to promote persistence of long-term memory storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Rapid stimulatory effects of brain-derived neurotrophic factor and neurotrophin-3 on somatostatin release and intracellular calcium rise in primary hypothalamic cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Stage-dependent BDNF serum concentrations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

'How far' vs 'how fast' in Alzheimer's disease. The question revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Involvement of VIP on BDNF-induced somatostatin gene expression in cultured fetal rat cerebral cortical cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Transport of brain-derived neurotrophic factor across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

A method for estimating progression rates in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

7 January 2021

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

7 January 2021

Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

7 January 2021

Brain-derived neurotrophic factor levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710001008

7 January 2021

10.1017/S1461145710001008

Identifiers

DOI

1 reference

27 March 2018

PubMed ID

20860877

1 reference

27 March 2018